Healthcare - Biotechnology - NASDAQ - GB
$ 31.59
-3.16 %
$ 1.58 B
Market Cap
-34.34
P/E
Price Target
Average
128.82%
Revenue Forecast
Estimate
25.98%
EBIT
Estimate
--65.11%
Net Income
Estimate
26.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immunocore Holdings plc
Wall Street analysts predict an average 1-year price target for IMCR of $72.3 , with forecasts ranging from a low of $24 to a high of $100 .
IMCR Lowest Price Target
Wall Street Target
24 USD
-24.03%
IMCR Average Price Target
Wall Street Target
72.3 USD
128.82%
IMCR Highest Price Target
Wall Street Target
100 USD
216.56%
REVENUE FORECAST
Revenue Forecast Chart IMCR
EBIT FORECAST
EBIT Forecast Chart IMCR
NET INCOME FORECAST
Net Income Chart IMCR